PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Phenotype | C0022658|renal disease |
| Sentences | 13 |
| PubMedID- 26095179 | Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of hepatitis c in patients with end stage renal disease. |
| PubMedID- 25767389 | Management of chronic hepatitis c virus infection in patients with end-stage renal disease: a review. |
| PubMedID- 23716924 | renal disease associated with hepatitis c virus (hcv) infection includes membranoproliferative glomerulonephritis commonly with or without cryoglobulinemia, and membranous glomerulopathy. |
| PubMedID- 22964112 | Optimization and application of subtype specific polymerase chain reaction for detection and identification of mixed subtypes of hepatitis c virus in patients with renal disease. |
| PubMedID- 25644891 | Detection of hepatitis c virus in patients with terminal renal disease undergoing dialysis in southern brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients. |
| PubMedID- 20150020 | Objective: to assess the histologic prevalence of immune-mediated thyroid, pituitary, and adrenal diseases in postmortem cases with hepatitis c. |
| PubMedID- 25894147 | In this study, we aimed to identify the severity of liver disease in endstage renal disease patients with chronic hepatitis c virus infection, the progression of hepatic histopathology after kidney transplant, and whether immunosuppressive therapy affected posttransplant viral replication and hepatic histology. |
| PubMedID- 22310778 | Cryoglobulinemic membranoproliferative glomerulonephritis (mpgn) is the more characteristic renal disease associated with hepatitis c virus (hcv) infection. |
| PubMedID- 23425817 | Eligible studies were cohort studies that analyzed adult end-stage renal disease patients with hepatitis c virus infection and compared death rates between waiting list and kidney transplantation. |
| PubMedID- 21261711 | Treatment of hepatitis c virus infection in patients with end-stage renal disease. |
| PubMedID- 21699813 | Full-dose peginterferon alfa-2a and low-dose ribavirin treatment of genotypes 1 and 4 chronic hepatitis c patients with end-stage renal disease. |
| PubMedID- 21796553 | Nevertheless, renal transplant can be considered as a safe and effective treatment modality in anti-hepatitis c virus-positive patients with end-stage renal disease. |
| PubMedID- 20056985 | Objective: end-stage renal disease (esrd) patients with hepatitis c virus (hcv) infection are associated with an increasing mortality risk on hemodialysis (hd) and peritoneal dialysis (pd). |
Page: 1